APSR2026-409

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP10-009
P09
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1220265-46904-APSR2026_DECAF_Poster_A0_433876.pdf
Format: PDF Only
07. COPD
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Agung Prabowo * Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Budhi Antariksa - Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Agus Dwi Susanto - Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Prasenohadi Prasenohadi - Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Agung
Prabowo
agungprabs20@gmail.com
+6282168113563
31-40
Indonesia
Original Research
Prognostic Utility of the DECAF Score for Readmission and Mortality in Acute COPD Exacerbations at Indonesia’s National Respiratory Referral Center
Maximum 25 words
Abstract Content
Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a major cause of hospitalization and mortality, with a high risk of recurrence. The DECAF score has been validated as a predictor of short-term mortality. However, evidence regarding its ability to predict readmission and mid-term mortality in Indonesia remains limited. This study aims to evaluate the association between the DECAF score and readmission as well as 45-day mortality among patients with COPD exacerbation.
This prospective longitudinal observational study included patients presenting with acute exacerbation of COPD to the Emergency Department between November 2025 and January 2026. The DECAF score was calculated within 24 hours of admission using eMRCD, eosinopenia, radiographic consolidation, arterial acidemia, and atrial fibrillation. Patients were followed for 45 days to assess hospital readmission and mortality. Associations between DECAF risk categories and outcomes were analyzed using univariate and bivariate methods, with statistical significance set at p < 0.05.
A total of 43 patients were included with a mean age of 65.5 ± 8.8 years. Five patients (11.6%) died within 30 days. Higher DECAF scores were significantly associated with greater care intensity requirements, including need for higher-level monitoring and advanced respiratory support (p = 0.007; Cramer’s V = 0.406), indicating a moderate strength of association. However, DECAF risk categories were not significantly associated with 45-day mortality (p = 0.462). Exacerbation severity demonstrated a significant independent association with care intensity in multivariate analysis. Additionally, length of hospital stay differed significantly across care intensity groups (H = 15.135; p < 0.001), with higher-intensity care corresponding to prolonged hospitalization
The DECAF score is a useful tool for early stratification of care intensity in acute COPD exacerbation. However, it did not predict short-term mortality or readmission, suggesting that additional clinical and post-discharge factors influence patient outcomes.
 
 
 
 
 
No
Yes
https://storage.unitedwebnetwork.com/files/1285/1220265-37089-Picture_379823.png
JPG or JPEG or PNG format ONLY
DECAF, Mortality, Readmission
maximum 3 keywords and no abbreviations, separated by commas
 
294